Ancora Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Ancora Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-8,000	Closed	-$220K	–	2357
2021 Q2	$220K	Hold	8,000	–	–	0.01%	735
2021 Q1	$132K	Buy	8,000 +1,200	+18%	+$27.3K	﹤0.01%	801
2020 Q4	$125K	Buy	6,800 +1,400	+26%	+$25.1K	﹤0.01%	711
2020 Q3	$73K	Buy	+5,400	New	+$83.3K	﹤0.01%	782

Ancora Advisors's TBIO Position: Q3 2021 in Review

Ancora Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 8,000 shares — an estimated $220K sold.

Ancora Advisors first reported a position in TBIO in Q3 2020 and held it in 4 quarters. The position peaked at $220K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Ancora Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Ancora Advisors sold 8,000 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $220K.
Ancora Advisors first reported a position in Translate Bio, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
Ancora Advisors's Translate Bio, Inc. Common Stock position peaked at $220K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Ancora Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.